IBEX Ltd. Announces CEO Appointment and Director Departure
Ticker: IBEX · Form: 8-K · Filed: Jan 6, 2025 · CIK: 1720420
| Field | Detail |
|---|---|
| Company | Ibex LTD (IBEX) |
| Form Type | 8-K |
| Filed Date | Jan 6, 2025 |
| Risk Level | medium |
| Pages | 4 |
| Reading Time | 4 min |
| Key Dollar Amounts | $0.0001, $75,000 |
| Sentiment | neutral |
Sentiment: neutral
Topics: leadership-change, ceo-appointment, director-departure
Related Tickers: IBEX
TL;DR
IBEX Ltd. has a new CEO, Michael E. Roffler, effective Dec 31, 2024. Roffler is also stepping down as a director.
AI Summary
IBEX Ltd. announced on December 31, 2024, the departure of Director Michael E. Roffler and the appointment of Michael E. Roffler as Chief Executive Officer. The company also reported on compensatory arrangements for certain officers.
Why It Matters
This filing signals a significant leadership change at IBEX Ltd. with the appointment of a new CEO, which could impact the company's strategic direction and operational performance.
Risk Assessment
Risk Level: medium — Leadership changes, especially the appointment of a CEO, can introduce uncertainty and affect strategic execution, warranting a medium risk assessment.
Key Players & Entities
- IBEX Ltd. (company) — Registrant
- Michael E. Roffler (person) — Director and Chief Executive Officer
- December 31, 2024 (date) — Effective date of changes
FAQ
Who has been appointed as the new Chief Executive Officer of IBEX Ltd.?
Michael E. Roffler has been appointed as the new Chief Executive Officer of IBEX Ltd.
When did the changes in leadership take effect?
The changes took effect on December 31, 2024.
What other role did Michael E. Roffler hold that is being affected by these changes?
Michael E. Roffler is departing from his role as a Director of IBEX Ltd.
What is the primary purpose of this Form 8-K filing?
This Form 8-K filing is to report the departure of a director, the election of directors, the appointment of certain officers, and compensatory arrangements of certain officers.
What is the exact name of the registrant?
The exact name of the registrant is IBEX Limited.
Filing Stats: 1,113 words · 4 min read · ~4 pages · Grade level 11.7 · Accepted 2025-01-06 16:49:24
Key Financial Figures
- $0.0001 — Registered Common shares, par value of $0.0001 IBEX Nasdaq Global Market Indicate by
- $75,000 — s, including an annual cash retainer of $75,000, prorated for any partial years of serv
Filing Documents
- ibex-20241231.htm (8-K) — 32KB
- exhibit991-pressreleasedat.htm (EX-99.1) — 8KB
- 0001720420-25-000002.txt ( ) — 173KB
- ibex-20241231.xsd (EX-101.SCH) — 2KB
- ibex-20241231_lab.xml (EX-101.LAB) — 23KB
- ibex-20241231_pre.xml (EX-101.PRE) — 13KB
- ibex-20241231_htm.xml (XML) — 3KB
01. Regulation FD Disclosure
Item 7.01. Regulation FD Disclosure. A copy of the press release announcing the matters described above is attached to this report as Exhibit 99.1 and incorporated herein by reference. The information contained in Item 7.01 and Exhibit 99.1 is being furnished and shall not be deemed "filed" for purposes of the Securities and Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities under that Section and shall not be deemed to be incorporated by reference into any filing of the Registrant under the Securities Act of 1933, as amended, or the Exchange Act, unless specifically identified therein as being incorporated by reference.
01. Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits. (d) Exhibits. EXHIBIT INDEX Exhibit No. Description 99.1 Press release, dated January 6, 2025 104 Cover Page Interactive Data File (formatted in Inline XBRL and contained in Exhibit 101)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. IBEX LIMITED (Registrant) Date: January 6, 2025 /s/ Robert Dechant (Signature) Name: Robert Dechant Title: Chief Executive Officer